HER2 intratumoral heterogeneity predicts response to neoadjuvant therapy in HER2-positive breast cancer: impact and interplay with HER3 expression
Angela Santoro(Istituto Tumori Bari), Antonino Mulè(Agostino Gemelli University Polyclinic)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
October 30, 2025
Cited by 0
Related Papers
Beta-Catenin and Epithelial Tumors: A Study Based on 374 Oropharyngeal Cancers
|BioMed Research International|2014|27